M&A Deal Summary

Inotiv Acquires Bolder BioPATH

On April 16, 2021, Inotiv acquired life science company Bolder BioPATH for 20M USD

Acquisition Highlights
  • This is Inotiv’s 4th transaction in the Life Science sector.
  • This is Inotiv’s 3rd largest (disclosed) transaction.
  • This is Inotiv’s 4th transaction in the United States.
  • This is Inotiv’s 2nd transaction in Colorado.

M&A Deal Summary
Date 2021-04-16
Target Bolder BioPATH
Sector Life Science
Buyer(s) Inotiv
Deal Type Add-on Acquisition
Deal Value 20M USD

Target

Bolder BioPATH

Boulder, Colorado, United States
Bolder BioPATH is a contract pharmacology and pathology company specializing in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of the central nervous system, and other autoimmune, inflammation, and pain models. Bolder BioPATH was founded in 2003 and is based in Boulder, Colorado.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Inotiv

West Lafayette, Indiana, United States
Category Company
Founded 1974
Sector Life Science
Employees1,955
Revenue 572M USD (2023)
DESCRIPTION

Inotiv is a pharmaceutical development company providing contract research services and niche instrumentation, serving both the life sciences industries, primarily in drug research and development. Inotiv was founded in 1974 and is based in West Lafayette, Indiana.

DEAL STATS #
Overall 4 of 9
Sector (Life Science) 4 of 8
Type (Add-on Acquisition) 3 of 7
State (Colorado) 2 of 3
Country (United States) 4 of 9
Year (2021) 2 of 3
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-04-13 HistoTox Labs

Boulder, Colorado, United States

HistoTox Labs is a full-service histopathology contract research organization (CRO) offering medically relevant non-clinical and clinical services to the pharmaceutical, biotech, and academic communities.

Buy $22M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-10-04 Plato BioPharma

Westminster, Colorado, United States

Plato BioPharma is a biotechnology company that engages in vivo pharmacology research and drug discovery company specializing in cardiovascular, renal, pulmonary, and hepatic therapeutic areas. Plato BioPharma was founded in 2009 and is based in Westminster, Colorado.

Buy $15M
Mergr

Product

Company

Legal